drugset / Trial / NCT03422692

Socket Preservation: A Clinical and Histological Study

NCT03422692 ↗

Phase 1 Completed 43 enrolled University of Kentucky
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to investigate the use of human amnion chorion membrane (BioXclude®) as an exposed barrier in ridge preservation and whether the intentional exposure of this membrane to oral environment will adversely affect ridge healing, dimensions, and bone vitality. This is a randomized clinical study.

Timeline

Start
2013-10-01
Primary completion
2015-10-01
Completion
2015-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject BioXclude Unknown — —
Comparator Mem-Lok Unknown — —

Indications

No indication recorded.